Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D002108:Ceruletide / Q000494:pharmacology*; D002766:Cholecystokinin / Q000031:analogs & derivatives* / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D051379:Mice; D011954:Receptors, Dopamine / Q000187:drug effects; D012844:Sincalide; D012890:Sleep / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects
D000927:Anticonvulsants; D002492:Central Nervous System Depressants; D011954:Receptors, Dopamine; D002108:Ceruletide; D002766:Cholecystokinin; D006220:Haloperidol; D012844:Sincalide; D003975:Diazepam